Cardinal Health (CAH) is back on investors’ radar after fresh company data highlighted revenue of about US$234.3b and net ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...

New NAHR Fellow and retiring CHRO Ola Snow of Cardinal Health says investment in culture has been critical to the ...

The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

Cardinal Health (CAH) closed at $210.93 in the latest trading session, marking a +1.25% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.5%. At the same time, the Dow added 0.

Cardinal Health has updated its financial outlook for fiscal year 2026 non-GAAP diluted earnings per share (EPS) to at least ...

Cardinal Health stock reached an all-time high of $215.54, marking a significant milestone for the $50.7 billion healthcare company. Over the past year, Cardinal Health has experienced a remarkable 66 ...

Cardinal Health (CAH) upgraded to Buy after a 100%+ run—see FY26 guidance, acquisitions, and nuclear medicine catalysts, plus ...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's ...

Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal Health, ...

DUBLIN, Ohio, Nov. 11, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into definitive agreements to acquire two companies that accelerate Cardinal Health's ...